The FDA lifts a clinical hold on Lpath's (LPTN.OB) iSONEP, an antibody the firm is developing to...

|About: Lpath Inc. (LPTN)|By:, SA News Editor

The FDA lifts a clinical hold on Lpath's (LPTN.OB) iSONEP, an antibody the firm is developing to treat wet AMD and possibly other eye disorders. The FDA placed the hold in January after finding that a contractor was not complying with its regulations, but Lpath has since replaced the supplier. (PR)